RLG
0.004
100%
ARO
0.002
-33.3%
H2G
0.011
37.5%
NAE
0.002
-33.3%
CPN
0.14
33.3%
CAY
0.06
-31%
WRX
0.024
26.3%
LAM
0.53
-29.8%
OVT
0.005
25%
LKO
0.35
-25.5%
RGL
0.01
25%
CAN
0.003
-25%
SOP
0.048
20%
CMO
0.006
-25%
AT4
0.049
19.5%
PER
0.003
-25%
CRN
0.195
18.2%
VRL
0.01
-23.1%
EVG
0.026
18.2%
ACM
0.026
-21.2%
MML
0.013
18.2%
GTE
0.008
-20%
APX
1.02
17.9%
OSX
0.004
-20%
AAU
0.007
16.7%
G50
0.53
-19.7%
H3E
0.007
16.7%
AGD
0.105
-19.2%
PGD
0.185
15.6%
DVP
4.6
-17.6%
USC
0.023
15%
FAU
0.005
-16.7%
CYC
0.595
14.4%
NFM
0.005
-16.7%
PXX
0.016
14.3%
OMG
0.005
-16.7%
VFY
3.5
13.3%
VHL
0.01
-16.7%
BIO
0.3
13.2%
C29
0.011
-15.4%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CMP FDA clearance

Compumedics (ASX:CMP) announces the US FDA has cleared the Somfit device to be marketed in the USA. This marks the achievement of another significant strategic milestone for the Somfit technology platform in one of the world’s largest sleep markets https://www.compumedics.com.au/en/asx-announcements/somfit-update2-2/ #shorts